These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2146977)

  • 1. In vitro interactions of the aromatic retinoids Ro 10-9359 (etretinate) and Ro 10-1670 (acitretin), its main metabolite, with human serum lipoproteins and albumin.
    Carillet V; Morlière P; Mazière JC; Hüppe G; Santus R; Dubertret L
    Biochim Biophys Acta; 1990 Nov; 1055(2):98-101. PubMed ID: 2146977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake of the aromatic retinoids Ro 10-9359 (etretinate) and Ro 10-1670 (acitretin), its main metabolite, delivered to cultured human fibroblasts by serum proteins. Lack of evidence for perturbation of LDL catabolism.
    Carillet V; Morlière P; Mazière JC; Hüppe G; Santus R; Dubertret L
    Biochim Biophys Acta; 1990 Nov; 1055(2):102-6. PubMed ID: 2146974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative binding of etretinate and acitretin to plasma proteins and erythrocytes.
    Urien S; Claudepierre P; Meyer J; Brandt R; Tillement JP
    Biochem Pharmacol; 1992 Nov; 44(9):1891-3. PubMed ID: 1449542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of Etretinate (Ro 10-9359) and its metabolite (Ro 10-1670).
    Ishizaki H; Masuda H; Kaseda H; Kaminaga T; Hirone T
    J Dermatol; 1983 Oct; 10(5):421-6. PubMed ID: 6230381
    [No Abstract]   [Full Text] [Related]  

  • 5. High-performance liquid chromatography of Ro 10-9359 (tigason) and its metabolite Ro 10-1670 in human plasma.
    Besner JG; Meloche S; Leclaire R; Band P; Mailhot S
    J Chromatogr; 1982 Sep; 231(2):467-72. PubMed ID: 6215418
    [No Abstract]   [Full Text] [Related]  

  • 6. UV-induced isomerization of oral retinoids in vitro and in vivo in hairless mice.
    Berne B; Rollman O; Vahlquist A
    Photodermatol Photoimmunol Photomed; 1990 Aug; 7(4):146-52. PubMed ID: 2150173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous determination of the aromatic retinoids etretin and etretinate and their main metabolites by reversed-phase liquid chromatography.
    Jakobsen P; Larsen FG; Larsen CG
    J Chromatogr; 1987 Apr; 415(2):413-8. PubMed ID: 2953748
    [No Abstract]   [Full Text] [Related]  

  • 8. Etretinate: effect of milk intake on absorption.
    DiGiovanna JJ; Gross EG; McClean SW; Ruddel ME; Gantt G; Peck GL
    J Invest Dermatol; 1984 Jun; 82(6):636-40. PubMed ID: 6233379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of retinoids in biological fluids by high-performance liquid chromatography using column switching. II. Simultaneous determination of etretinate, acitretin and 13-cis-acitretin in plasma.
    Wyss R; Bucheli F
    J Chromatogr; 1988 Oct; 431(2):297-307. PubMed ID: 2977389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-performance liquid chromatographic determination of etretinate and all-trans- and 13-cis-acitretin in human plasma.
    De Leenheer AP; Lambert WE; De Bersaques JP; Kint AH
    J Chromatogr; 1990 Feb; 500():637-42. PubMed ID: 2139439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of plasma levels of two aromatic retinoic acid analogues with antipsoriatic activity by high-performance liquid chromatography.
    Palmskog G
    J Chromatogr; 1980 Dec; 221(2):345-51. PubMed ID: 6452462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of pregnancy on the pharmacokinetic disposition of two aromatic retinoids (etretinate and acitretin) in the rat. I. Intravenous studies.
    Brouwer KR; McNamara PJ
    Drug Metab Dispos; 1989; 17(6):646-51. PubMed ID: 2575501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Teratogenicity of steady-state concentrations of etretinate and metabolite acitretin maintained in maternal plasma and embryo by intragastric infusion during organogenesis in the mouse: a possible model for the extended elimination phase in human therapy.
    Löfberg B; Reiners J; Spielmann H; Nau H
    Dev Pharmacol Ther; 1990; 15(1):45-51. PubMed ID: 2147001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous microassay for etretinate and its active metabolite, etretin, by reversed-phase high-performance liquid chromatography.
    Thongnopnua P; Zimmerman CL
    J Chromatogr; 1988 Dec; 433():345-51. PubMed ID: 2976770
    [No Abstract]   [Full Text] [Related]  

  • 15. Retinoid concentrations in skin, serum and adipose tissue of patients treated with etretinate.
    Rollman O; Vahlquist A
    Br J Dermatol; 1983 Oct; 109(4):439-47. PubMed ID: 6226308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fish oil supplementation results in decreased hypertriglyceridemia in patients with psoriasis undergoing etretinate or acitretin therapy.
    Ashley JM; Lowe NJ; Borok ME; Alfin-Slater RB
    J Am Acad Dermatol; 1988 Jul; 19(1 Pt 1):76-82. PubMed ID: 2969924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic profile of two aromatic retinoids (etretinate and acitretin) in the obese Zucker rat.
    McNamara PJ; Blouin RA
    J Pharm Sci; 1990 Apr; 79(4):301-4. PubMed ID: 2141075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acitretin (Ro 10-1670) in the treatment of severe psoriasis. A randomized double-blind parallel study comparing acitretin and etretinate.
    Ledo A; Martín M; Geiger JM; Marrón JM
    Int J Dermatol; 1988 Nov; 27(9):656-60. PubMed ID: 2976406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Etretinate: pro and con. Risk-benefit analysis of systemic retinoid therapy in psoriasis and recent developments: free aromatic acid, arotinoids].
    Gollnick H; Orfanos CE
    Hautarzt; 1985 Jan; 36(1):2-9. PubMed ID: 3156105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biotransformation of etretinate and developmental toxicity of etretin and other aromatic retinoids in teratogenesis bioassays.
    Kochhar DM; Penner JD; Minutella LM
    Drug Metab Dispos; 1989; 17(6):618-24. PubMed ID: 2575497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.